Tissue Microarrays in clinical oncology

被引:95
作者
Voduc, David [1 ]
Kenney, Challayne [2 ]
Nielsen, Torsten O. [3 ]
机构
[1] British Columbia Canc Agcy, Dept Radiat Oncol, Vancouver, BC V5Z 4E6, Canada
[2] Genet Pathol Evaluat Ctr, Vancouver, BC, Canada
[3] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
10.1016/j.semradonc.2007.10.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tissue microarray (TMA) is a recently implemented, high-throughput technology for the analysis of molecular markers in oncology. This research tool permits the rapid assessment of a biomarker in thousands of tumor samples, using commonly available laboratory assays such as immunohistochemistry and in situ hybridization. Although introduced less than a decade ago, TMA has proven to be invaluable in the study of tumor biology, the development of diagnostic tests, and the investigation of oncologic biomarkers. This review describes the impact of TMA-based research in clinical oncology and its potential future applications. Technical aspects of TMA construction and the advantages and disadvantages inherent to this technology are also discussed.
引用
收藏
页码:89 / 97
页数:9
相关论文
共 57 条
[41]   p27Kip1 and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy [J].
Porter, Peggy L. ;
Barlow, William E. ;
Yeh, I-Tien ;
Lin, Ming Gang ;
Yuan, Xiaopu P. ;
Donato, Elizabeth ;
Sledge, George W. ;
Shapiro, Charles L. ;
Ingle, James N. ;
Haskell, Charles M. ;
Albain, Kathy S. ;
Roberts, James M. ;
Livingston, Robert B. ;
Hayes, Daniel F. .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (23) :1723-1731
[42]   Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis [J].
Psyrri, A ;
Yu, ZW ;
Weinberger, PM ;
Sasaki, C ;
Haffty, B ;
Camp, R ;
Rimm, D ;
Burtness, BA .
CLINICAL CANCER RESEARCH, 2005, 11 (16) :5856-5862
[43]   Opinion - Rules of evidence for cancer molecular-marker discovery and validation [J].
Ransohoff, DF .
NATURE REVIEWS CANCER, 2004, 4 (04) :309-314
[44]   Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer [J].
Ravdin, PM ;
Siminoff, LA ;
Davis, GJ ;
Mercer, MB ;
Hewlett, J ;
Gerson, N ;
Parker, HL .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :980-991
[45]   Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure [J].
Sapino, Anna ;
Marchio, Caterina ;
Senetta, Rebecca ;
Castellano, Isabella ;
Macri, Luigia ;
Cassoni, Paola ;
Ghisolfl, Giampiero ;
Cerrato, Milena ;
D'Ambrosio, Enrico ;
Bussolati, Gianni .
VIRCHOWS ARCHIV, 2006, 449 (03) :288-296
[46]   c-erbB-2 (HER-2/neu) immunohistochemistry in invasive breast cancer: is there concordance between standard sections and tissue microarrays? [J].
Selvarajan, Sathiyamoorthy ;
Tan, Soo Yong ;
Sii, Lang Hiong ;
Tan, Puay Hoon .
PATHOLOGY, 2006, 38 (04) :316-320
[47]   Tissue microarrays for miniaturized high-throughput molecular profiling of tumors [J].
Simon, R ;
Sauter, G .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (12) :1365-1372
[48]   Repeated observation of breast tumor subtypes in independent gene expression data sets [J].
Sorlie, T ;
Tibshirani, R ;
Parker, J ;
Hastie, T ;
Marron, JS ;
Nobel, A ;
Deng, S ;
Johnsen, H ;
Pesich, R ;
Geisler, S ;
Demeter, J ;
Perou, CM ;
Lonning, PE ;
Brown, PO ;
Borresen-Dale, AL ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (14) :8418-8423
[49]   Nomograms for prostate cancer [J].
Stephenson, Andrew J. ;
Kattan, Michael W. .
BJU INTERNATIONAL, 2006, 98 (01) :39-46
[50]   Comparison of annexin II, p63 and α-methylacyl-CoA racemase immunoreactivity in prostatic tissue:: a tissue microarray study [J].
Stewart, Jocelyn ;
Fleshner, Neil ;
Cole, Heather ;
Sweet, Joan .
JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (07) :773-780